FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

P L C M van Riel

Research Profile

Disorders

Rheumatoid Arthritis

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
A I M van Laarhoven; P L C M van Riel; A L Walker; O H Wilder-Smith; Floris W Kraaimaat; S Kroeze; P C M van de Kerkhof; A W M Evers
Role of induced negative and positive emotions in sensitivity to itch and pain in women.
Thomas Hoogeboom; G F Snijders; F H J van den Hoogen; P L C M van Riel; J Wesseling; S M A Bierma-Zeinstra; H A Cats; R A de Bie; Alfons A den Broeder; P J Emans; C H M van den Ende
Prevalence and predictors of health care use in patients with early hip or knee osteoarthritis: two-year follow-up data from the CHECK cohort.
Daniel E Furst; Allan Gibofsky; JR Kalden; Arthur F Kavanaugh; Edward C Keystone; B Kirkham; Philip J Mease; J Sieper; N G Singer; JS Smolen; P L C M van Riel; Michael H Weisman; Jonathan Braun; Ferdinand C Breedveld; Gerd R Burmester; de benedetti fabrizio; T Dörner; P Emery; Roy Fleischmann; Kevin L Winthrop
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of P L C M van Riel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A I M van Laarhoven; P L C M van Riel; A L Walker; O H Wilder-Smith; Floris W Kraaimaat; S Kroeze; P C M van de Kerkhof; A W M Evers
Role of induced negative and positive emotions in sensitivity to itch and pain in women.
The British journal of dermatology 2012;167(2):262-9.
2012: Thomas Hoogeboom; G F Snijders; F H J van den Hoogen; P L C M van Riel; J Wesseling; S M A Bierma-Zeinstra; H A Cats; R A de Bie; Alfons A den Broeder; P J Emans; C H M van den Ende
Prevalence and predictors of health care use in patients with early hip or knee osteoarthritis: two-year follow-up data from the CHECK cohort.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2012;20(6):525-31.
2012: Daniel E Furst; Allan Gibofsky; JR Kalden; Arthur F Kavanaugh; Edward C Keystone; B Kirkham; Philip J Mease; J Sieper; N G Singer; JS Smolen; P L C M van Riel; Michael H Weisman; Jonathan Braun; Ferdinand C Breedveld; Gerd R Burmester; de benedetti fabrizio; T Dörner; P Emery; Roy Fleischmann; Kevin L Winthrop
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
Annals of the rheumatic diseases 2012;71 Suppl 2():i2-45.
2012: Mark Wenink; P Garside; A M Platt; T R D J Radstake; K C M Santegoets; Wim B van den Berg; P L C M van Riel; I B McInnes
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation.
Annals of the rheumatic diseases 2012;71(1):80-3.
2011: S van Koulil; Wim van Lankveld; P L C M van Riel; A Vedder; L Wirken; H Cats; A R T Donders; Floris W Kraaimaat; T van Helmond; H van Hoorn; A W M Evers
Tailored cognitive-behavioural therapy and exercise training improves the physical fitness of patients with fibromyalgia.
Annals of the rheumatic diseases 2011;70(12):2131-3.
2011: L T C van Hulst; P L C M van Riel; W Kievit; R van Bommel; L Fraenkel
Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
Arthritis care & research 2011;63(10):1407-14.
2011: S van Koulil; Floris W Kraaimaat; Wim van Lankveld; T van Helmond; A Vedder; H van Hoorn; A R T Donders; K Thieme; H Cats; P L C M van Riel; A W M Evers
Cognitive-behavioral mechanisms in a pain-avoidance and a pain-persistence treatment for high-risk fibromyalgia patients.
Arthritis care & research 2011;63(6):800-7.
2011: G F Snijders; V H H P Straten; C H M van den Ende; F H J van den Hoogen; P L C M van Riel; F H R de Man; A A den Broeder
Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing.
Scandinavian journal of rheumatology 2011;40(3):225-31.
2011: E E A Arts; Tim Jansen; A Den Broeder; H E Vonkeman; E Dutmer; M A F J van de Laar; P L C M van Riel; Jaap Fransen
Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
Annals of the rheumatic diseases 2011;70(5):877-8.
2011: Daniel E Furst; Edward C Keystone; J Braun; Ferdinand C Breedveld; Gerd R Burmester; de benedetti fabrizio; T Dörner; P Emery; Roy Fleischmann; Allan Gibofsky; JR Kalden; A Kavanaugh; B Kirkham; Philip J Mease; J Sieper; N G Singer; JS Smolen; P L C M van Riel; Michael H Weisman; Kevin L Winthrop
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.
Annals of the rheumatic diseases 2011;70 Suppl 1():i2-36.
2010: M Blom; W Kievit; H H Kuper; Tim Jansen; H Visser; Alfons A den Broeder; H L M Brus; M A F J van de Laar; P L C M van Riel
Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice.
Arthritis care & research 2010;62(9):1335-41.
2010: FJ van der Giesen; W van Lankveld; M Hopman-Rock; Zuzana de Jong; Marten Munneke; J M W Hazes; P L C M van Riel; Andreas J Peeters; H Karel Ronday; T P M Vliet Vlieland
Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation study.
Arthritis care & research 2010;62(6):865-72.
2010: B J Radovits; Jaap Fransen; S Al Shamma; A M M Eijsbouts; P L C M van Riel; R F J M Laan
Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.
Arthritis care & research 2010;62(3):362-70.
2010: Chin Teck Ng; B J Radovits; W Kievit; Jaap Fransen; P L C M van Riel; O FitzGerald; douglas veale; B Bresnihan
Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing.
Annals of the rheumatic diseases 2010;69(1):313-4.
2010: Daniel E Furst; Edward C Keystone; Roy Fleischmann; Philip J Mease; Ferdinand C Breedveld; JS Smolen; JR Kalden; Jonathan Braun; B Bresnihan; Gerd R Burmester; de benedetti fabrizio; T Dörner; P Emery; Allan Gibofsky; Arthur F Kavanaugh; B Kirkham; Michael H Schiff; J Sieper; N Singer; P L C M van Riel; Michael E Weinblatt; Michael H Weisman; Kevin L Winthrop
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.
Annals of the rheumatic diseases 2010;69 Suppl 1():i2-29.
2009: L T C van Hulst; Jaap Fransen; Alfons A den Broeder; Richard Grol; P L C M van Riel; Marlies E J L Hulscher
Development of quality indicators for monitoring of the disease course in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(12):1805-10.
2009: T R D J Radstake; M Svenson; A M M Eijsbouts; F H J van den Hoogen; C Enevold; P L C M van Riel; Klaus Bendtzen
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(11):1739-45.
2009: Lydia G Schipper; Jaap Fransen; Pilar Barrera; Alfons A den Broeder; P L C M van Riel
Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
Rheumatology (Oxford, England) 2009;48(10):1247-53.
2009: B J Radovits; W Kievit; Jaap Fransen; M A F J van de Laar; Tim Jansen; P L C M van Riel; R F J M Laan
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(9):1470-3.
2009: Mieke F Roelofs; Mark Wenink; F Brentano; Shahla Abdollahi-Roodsaz; Birgitte Oppers-Walgreen; Pilar Barrera; P L C M van Riel; Leo A B Joosten; D Kyburz; Wim B van den Berg; T R D J Radstake
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
Annals of the rheumatic diseases 2009;68(9):1486-93.
2009: B J Radovits; D A Popa-Diaconu; Calin Popa; A M M Eijsbouts; R F J M Laan; P L C M van Riel; Jaap Fransen
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(8):1271-6.
2009: Cees J Tack; F S Kleijwegt; P L C M van Riel; B O Roep
Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis.
Diabetologia 2009;52(7):1442-4.
2009: Calin Popa; Lambertus J H Van Tits; Pilar Barrera; H L M Lemmers; F H J van den Hoogen; P L C M van Riel; T R D J Radstake; Mihai G Netea; M Roest; Anton F H Stalenhoef
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
Annals of the rheumatic diseases 2009;68(6):868-72.
2009: Antoine W T van Lieshout; Robbert van der Voort; L W J Toonen; S F G van Helden; Carl G Figdor; P L C M van Riel; T R D J Radstake; Gosse J Adema
Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis.
Annals of the rheumatic diseases 2009;68(6):1036-43.
2009: George Wells; J-C Becker; J Teng; Maxime Dougados; M Schiff; Josef Smolen; Daniel Aletaha; P L C M van Riel
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
Annals of the rheumatic diseases 2009;68(6):954-60.
2009: A W T van Lieshout; Madelon C Vonk; S J H Bredie; L B A Joosten; Mihai G Netea; P L C M van Riel; Robert Lafyatis; F H J van den Hoogen; T R D J Radstake
Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
Scandinavian journal of rheumatology 2009;38(4):282-90.
2008: Daniel E Furst; Edward C Keystone; B Kirkham; A Kavanaugh; Roy Fleischmann; Philip J Mease; Ferdinand C Breedveld; JS Smolen; JR Kalden; Gerd R Burmester; J Braun; P Emery; Kevin L Winthrop; B Bresnihan; de benedetti fabrizio; T Dörner; Allan Gibofsky; Michael H Schiff; J Sieper; N Singer; P L C M van Riel; Michael E Weinblatt; Michael H Weisman
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Annals of the rheumatic diseases 2008;67 Suppl 3():iii2-25.
2008: Erik J M Toonen; Pilar Barrera; T R D J Radstake; P L C M van Riel; Hans Scheffer; B Franke; Marieke Coenen
Gene expression profiling in rheumatoid arthritis: current concepts and future directions.
Annals of the rheumatic diseases 2008;67(12):1663-9.
2008: B J F van den Bemt; A A den Broeder; G F Snijders; Y A Hekster; P L C M van Riel; B Benraad; G J Wolbink; F H J van den Hoogen
Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
Annals of the rheumatic diseases 2008;67(12):1697-701.
2008: T Karonitsch; Daniel Aletaha; M Boers; S Bombardieri; B Combe; Maxime Dougados; P Emery; D Felson; J Gomez-Reino; E Keystone; T K Kvien; E Martin-Mola; M Matucci-Cerinic; P Richards; P L C M van Riel; J Siegel; Josef S Smolen; T Sokka; Désirée van der Heijde; R van Vollenhoven; M Ward; G Wells; Angela Zink; R Landewe
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(10):1365-73.
2008: Madelon C Vonk; CE van Die; M M Snoeren; K J Bhansing; P L C M van Riel; Jaap Fransen; F H J van den Hoogen
Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma.
Annals of the rheumatic diseases 2008;67(9):1317-21.
2008: Erik J M Toonen; Marieke Coenen; W Kievit; Jaap Fransen; A M M Eijsbouts; Hans Scheffer; Timothy Radstake; M C W Creemers; D-J R A M de Rooij; P L C M van Riel; B Franke; Pilar Barrera
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(8):1174-7.
2008: B J Radovits; Jaap Fransen; P L C M van Riel; R F J M Laan
Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(8):1127-31.
2008: P L C M van Riel; B Freundlich; D MacPeek; R Pedersen; J R Foehl; A Singh
Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
Annals of the rheumatic diseases 2008;67(8):1104-10.
2008: Martine M Veehof; Peter M ten Klooster; Erik Taal; P L C M van Riel; M A F J van de Laar
Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.
Annals of the rheumatic diseases 2008;67(6):789-93.
2008: H J E M Janssens; M Janssen; Eloy H van de Lisdonk; P L C M van Riel; Chris van Weel
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.
Lancet 2008;371(9627):1854-60.
2008: Peter M ten Klooster; Martine M Veehof; Erik Taal; P L C M van Riel; M A F J van de Laar
Confirmatory factor analysis of the Arthritis Impact Measurement Scales 2 short form in patients with rheumatoid arthritis.
Arthritis and rheumatism 2008;59(5):692-8.
2008: Antoine W T van Lieshout; Marjonne C W Creemers; Timothy Radstake; Lammy D Elving; P L C M van Riel
Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
The Journal of rheumatology 2008;35(5):938-9.
2008: S van Koulil; Wim van Lankveld; Floris W Kraaimaat; T van Helmond; A Vedder; H van Hoorn; H Cats; P L C M van Riel; Andrea W M Evers
Tailored cognitive-behavioral therapy for fibromyalgia: two case studies.
Patient education and counseling 2008;71(2):308-14.
2008: Mieke F Roelofs; Mark Wenink; Erik J M Toonen; Marieke Coenen; Leo A B Joosten; Wim B van den Berg; P L C M van Riel; Timothy Radstake
The functional variant (Asp299gly) of toll-like receptor 4 (TLR4) influences TLR4-mediated cytokine production in rheumatoid arthritis.
The Journal of rheumatology 2008;35(4):558-61.
2008: Martine M Veehof; Peter M ten Klooster; Erik Taal; P L C M van Riel; M A F J van de Laar
Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.
The Journal of rheumatology 2008;35(4):610-7.
2008: S van Koulil; Floris W Kraaimaat; Wim van Lankveld; T van Helmond; A Vedder; H van Hoorn; H Cats; P L C M van Riel; Andrea W M Evers
Screening for pain-persistence and pain-avoidance patterns in fibromyalgia.
International journal of behavioral medicine 2008;15(3):211-20.
2008: Timothy Radstake; Jaap Fransen; P L C M van Riel; Erik J M Toonen; Marieke Coenen; Rachelle Donn
Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(1):134-5.
2007: Daniel E Furst; Ferdinand C Breedveld; JR Kalden; JS Smolen; Gerd R Burmester; J Sieper; P Emery; Edward C Keystone; Michael H Schiff; Philip J Mease; P L C M van Riel; Roy Fleischmann; Michael H Weisman; Michael E Weinblatt
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Annals of the rheumatic diseases 2007;66 Suppl 3():iii2-22.
2007: Han Repping-Wuts; Jaap Fransen; Theo van Achterberg; Gijs Bleijenberg; P L C M van Riel
Persistent severe fatigue in patients with rheumatoid arthritis.
Journal of clinical nursing 2007;16(11C):377-83.
2007: Behrooz Alizadeh; Gustavo Valdigem; Marieke Coenen; Alexandra Zhernakova; Barbara Franke; Alienke J Monsuur; P L C M van Riel; Pilar Barrera; Timothy Radstake; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.
Human molecular genetics 2007;16(21):2552-9.
2007: Calin Popa; F H J van den Hoogen; Timothy Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; P L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(11):1503-7.
2007: Peter M ten Klooster; Martine M Veehof; Erik Taal; P L C M van Riel; M A F J van de Laar
Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.
Annals of the rheumatic diseases 2007;66(11):1485-90.
2007: Timothy Radstake; Jaap Fransen; Erik J M Toonen; Marieke Coenen; Agnes E Eijsbouts; Rachelle Donn; F H J van den Hoogen; P L C M van Riel
Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(11):1525-30.
2007: W Kievit; Jaap Fransen; A J M Oerlemans; H H Kuper; M A F J van der Laar; D J R A M de Rooij; C M A De Gendt; K H Ronday; Tim Jansen; P C M van Oijen; H L M Brus; Eddy M M Adang; P L C M van Riel
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.
Annals of the rheumatic diseases 2007;66(11):1473-8.
2007: A I M van Laarhoven; Floris W Kraaimaat; Oliver H G Wilder-Smith; P C M van de Kerkhof; H Cats; P L C M van Riel; Andrea W M Evers
Generalized and symptom-specific sensitization of chronic itch and pain.
Journal of the European Academy of Dermatology and Venereology : JEADV 2007;21(9):1187-92.
2007: P L C M van Riel; Jaap Fransen
Established rheumatoid arthritis: clinical assessments.
Best practice & research. Clinical rheumatology 2007;21(5):807-25.
2007: Antoine W T van Lieshout; Jaap Fransen; Marcel Flendrie; A M M Eijsbouts; F H J van den Hoogen; P L C M van Riel; Timothy Radstake
Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(10):1334-8.
2007: Madelon C Vonk; M H Sander; F H J van den Hoogen; P L C M van Riel; Freek W A Verheugt; A P J van Dijk
Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2007;8(5):317-21.
2007: Madelon C Vonk; F H J van den Hoogen; P L C M van Riel; Gabriele Valentini
What does the clinician need to improve patient care in systemic sclerosis?
Annals of the rheumatic diseases 2007;66(9):1129-31.
2007: Annelies van Ede; Alfons A den Broeder; Michiel Wagenaar; P L C M van Riel; M C W Creemers
Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis.
The Journal of rheumatology 2007;34(7):1590-2.
2007: S van Koulil; M Effting; Floris W Kraaimaat; Wim van Lankveld; T van Helmond; H Cats; P L C M van Riel; A J L de Jong; J F Haverman; Andrea W M Evers
Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions.
Annals of the rheumatic diseases 2007;66(5):571-81.
2007: Antoine W T van Lieshout; Calin Popa; Friederike Meyer-Wentrup; H L M Lemmers; Anton F H Stalenhoef; Gosse J Adema; P L C M van Riel; Lambertus J H Van Tits; Timothy Radstake
Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis.
Biochemical and biophysical research communications 2007;355(2):392-7.
2007: Calin Popa; Mihai G Netea; P L C M van Riel; Jos W M van der Meer; Anton F H Stalenhoef
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.
Journal of lipid research 2007;48(4):751-62.
2007: Wouter V Vogel; P L C M van Riel; Wim J G Oyen
FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus.
European journal of nuclear medicine and molecular imaging 2007;34(3):439.
2007: M Blom; P L C M van Riel
Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
Best practice & research. Clinical rheumatology 2007;21(1):43-57.
2007: Niels P Riksen; Gerard A Rongen; Paul Smits; P L C M van Riel; Pilar Barrera
Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
Arthritis and rheumatism 2007;56(2):694; author reply 694-5.
2007: M Boers; J W G Jacobs; T P M van Vliet Vlieland; P L C M van Riel
Consensus Dutch health assessment questionnaire.
Annals of the rheumatic diseases 2007;66(1):132-3.
2007: Marcel Flendrie; M C W Creemers; P L C M van Riel
Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
Rheumatology (Oxford, England) 2007;46(1):146-9.
2006: Timothy Radstake; Barbara Franke; Mark Wenink; K C A M Nabbe; Marieke Coenen; Paco M J Welsing; Ezio Bonvini; Scott Koenig; Wim B van den Berg; Pilar Barrera; P L C M van Riel
The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(12):3828-37.
2006: Antoine W T van Lieshout; Calin Popa; P L C M van Riel; Timothy Radstake
Can CXCL16 be linked to coronary vascular disease? Comment on the article by Sheikine et al.
Atherosclerosis 2006;189(2):470-1; author reply 472-3.
2006: Jaap Fransen; P L C M van Riel
DAS remission cut points.
Clinical and experimental rheumatology 2006;24(6 Suppl 43):S-29-32.
2006: Michael E Weinblatt; P L C M van Riel
Targeted therapies: summary clinical trials working group.
Annals of the rheumatic diseases 2006;65 Suppl 3():iii89.
2006: Daniel E Furst; Ferdinand C Breedveld; JR Kalden; JS Smolen; Gerd R Burmester; P Emery; Edward C Keystone; Michael H Schiff; P L C M van Riel; Michael E Weinblatt; Michael H Weisman
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.
Annals of the rheumatic diseases 2006;65 Suppl 3():iii2-15.
2006: P L C M van Riel; A J Taggart; Jacques Sany; M Gaubitz; H W Nab; Ronald Pedersen; B Freundlich; D MacPeek
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study.
Annals of the rheumatic diseases 2006;65(11):1478-83.
2006: W Kievit; Paco M J Welsing; Eddy M M Adang; A M Eijsbouts; Paul Krabbe; P L C M van Riel
Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health.
Arthritis and rheumatism 2006;55(5):745-50.
2006: Calin Popa; Antoine W T van Lieshout; Mieke F Roelofs; Anneke Geurts-Moespot; P L C M van Riel; Thierry Calandra; Fred C G J Sweep; Timothy Radstake
MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis.
Cytokine 2006;36(1-2):51-6.
2006: Jaap Fransen; Christian Antoni; Philip J Mease; Wolfgang Uter; A Kavanaugh; Joachim R Kalden; P L C M van Riel
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.
Annals of the rheumatic diseases 2006;65(10):1373-8.
2006: Michiel M Zandbelt; Jos G A Houbiers; F H J van den Hoogen; Jan Meijerink; P L C M van Riel; Joanneke in't Hout; L B A Van De Putte
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.
The Journal of rheumatology 2006;33(9):1726-33.
2006: Linda M P le Blanc; Antoine W T van Lieshout; Gosse J Adema; P L C M van Riel; Marcel M Verbeek; Timothy Radstake
CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement.
Neuroscience letters 2006;397(1-2):145-8.
2006: Mark Wenink; Wim B van den Berg; P L C M van Riel; Timothy Radstake
Fc gamma receptor mediated modulation of dendritic cells as a potential strategy in the battle against rheumatoid arthritis.
The Netherlands journal of medicine 2006;64(4):103-8.
2006: Niels P Riksen; Pilar Barrera; Petra H H van den Broek; P L C M van Riel; Paul Smits; Gerard A Rongen
Methotrexate modulates the kinetics of adenosine in humans in vivo.
Annals of the rheumatic diseases 2006;65(4):465-70.
2006: Paco M J Welsing; George F Borm; P L C M van Riel
Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective.
The Journal of rheumatology 2006;33(3):501-7.
2006: Paco M J Welsing; Johan L Severens; Margriet Hartman; Anke M van Gestel; P L C M van Riel; R F J M Laan
The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis.
PharmacoEconomics 2006;24(10):1011-20.
2006: Antoine W T van Lieshout; Robbert van der Voort; Linda M P le Blanc; Mieke F Roelofs; B Willem Schreurs; P L C M van Riel; Gosse J Adema; Timothy Radstake
Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid.
BMC immunology 2006;7():23.
2005: Timothy Radstake; Antoine W T van Lieshout; P L C M van Riel; Wim B van den Berg; Gosse J Adema
Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(11):1532-8.
2005: George A Wells; Maarten Boers; Beverley Shea; Peter M Brooks; Lee S Simon; C Vibeke Strand; Daniel Aletaha; Jennifer J Anderson; Claire Bombardier; Maxime Dougados; Paul Emery; David T Felson; Jaap Fransen; Dan E Furst; J M W Hazes; Kent R Johnson; John R Kirwan; Robert B M Landewé; Marissa Lassere; Kaleb Michaud; Maria Suarez Almazor; Alan J Silman; Josef S Smolen; Desiree M F M Van der Heijde; P L C M van Riel; Fred Wolfe; Peter Tugwell
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
The Journal of rheumatology 2005;32(10):2016-24.
2005: Timothy Radstake; Fred C G J Sweep; Paco M J Welsing; Barbara Franke; Sita H H M Vermeulen; Anneke Geurts-Moespot; Thierry Calandra; Rachelle Donn; P L C M van Riel
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Arthritis and rheumatism 2005;52(10):3020-9.
2005: P L C M van Riel; J Fransen
To be in remission or not: is that the question?
Annals of the rheumatic diseases 2005;64(10):1389-90.
2005: E H J G Aarntzen; P L C M van Riel; Pilar Barrera
Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
Annals of the rheumatic diseases 2005;64(10):1523-4.
2005: Jaap Fransen; P L C M van Riel
The Disease Activity Score and the EULAR response criteria.
Clinical and experimental rheumatology 2005;23(5 Suppl 39):S93-9.
2005: Paco M J Welsing; Jaap Fransen; P L C M van Riel
Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
Arthritis and rheumatism 2005;52(9):2616-24.
2005: Jaap Fransen; H Bernelot Moens; I Speyer; P L C M van Riel
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.
Annals of the rheumatic diseases 2005;64(9):1294-8.
2005: Joachim R Kalden; Christian Antoni; Jose M Alvaro-Gracia; Bernard Combe; Paul Emery; Joel M Kremer; C Vibeke Strand; P L C M van Riel; Josef S Smolen
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.
The Journal of rheumatology 2005;32(8):1620-31.
2005: Calin Popa; Mihai G Netea; Timothy Radstake; P L C M van Riel; Pilar Barrera; J W M Van Der Meer
Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(8):1195-8.
2005: Calin Popa; Mihai G Netea; Pilar Barrera; Timothy Radstake; P L C M van Riel; Bart Jan Kullberg; Jos W M van der Meer
Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
Cytokine 2005;30(2):72-7.
2005: Wim B van den Berg; P L C M van Riel
Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality?
Arthritis and rheumatism 2005;52(4):995-9.
2005: Marcel Flendrie; M C W Creemers; Paco M J Welsing; P L C M van Riel
The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Rheumatology (Oxford, England) 2005;44(4):472-8.
2005: Antoine W T van Lieshout; Pilar Barrera; R L Smeets; Gerard J Pesman; P L C M van Riel; Wim B van den Berg; Timothy Radstake
Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(3):408-14.
2005: C Popa; M G Netea; Timothy Radstake; J W M Van der Meer; Anton F H Stalenhoef; P L C M van Riel; P Barerra
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(2):303-5.
2005: P L C M van Riel; Jaap Fransen
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis.
Arthritis research & therapy 2005;7(5):189-90.
2005: Marcel Flendrie; W H P M Vissers; M C W Creemers; Elke M G J de Jong; P C M van de Kerkhof; P L C M van Riel
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Arthritis research & therapy 2005;7(3):R666-76.
2005: M C W Creemers; M J A M Franssen; M A van't Hof; F W J Gribnau; L B A Van De Putte; P L C M van Riel
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.
Annals of the rheumatic diseases 2005;64(1):127-9.
2004: Paco M J Welsing; Johan L Severens; Margriet Hartman; P L C M van Riel; R F J M Laan
Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.
Arthritis and rheumatism 2004;51(6):964-73.
2004: Timothy Radstake; Mieke F Roelofs; Yvonne Bastiaansen-Jenniskens; Birgitte Oppers-Walgreen; P L C M van Riel; Pilar Barrera; Leo A B Joosten; Wim B van den Berg
Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
Arthritis and rheumatism 2004;50(12):3856-65.
2004: Jaap Fransen; R F J M Laan; M A F J van der Laar; Tom W J Huizinga; P L C M van Riel
Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis.
Annals of the rheumatic diseases 2004;63(10):1222-6.
2004: Jaap Fransen; M C W Creemers; P L C M van Riel
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.
Rheumatology (Oxford, England) 2004;43(10):1252-5.
2004: Paco M J Welsing; Robert B M Landewé; P L C M van Riel; Maarten Boers; Anke M van Gestel; Sjef van der Linden; Hilde L Swinkels; Désirée van der Heijde
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.
Arthritis and rheumatism 2004;50(7):2082-93.
2004: Joachim R Kalden; Josef S Smolen; Paul Emery; P L C M van Riel; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
Lefunomide in combination therapy.
The Journal of rheumatology. Supplement 2004;71():25-30.
2004: P L C M van Riel; Josef S Smolen; Paul Emery; Joachim R Kalden; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
Leflunomide: a manageable safety profile.
The Journal of rheumatology. Supplement 2004;71():21-4.
2004: Josef S Smolen; Paul Emery; Joachim R Kalden; P L C M van Riel; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
The Journal of rheumatology. Supplement 2004;71():13-20.
2004: L B A Van De Putte; C Atkins; Michel Malaise; Jacques Sany; A S Russell; P L C M van Riel; Lucas Settas; J W J Bijlsma; S Todesco; Maxime Dougados; P Nash; P Emery; N Walter; M Kaul; Steven Fischkoff; Hartmut Kupper
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.
Annals of the rheumatic diseases 2004;63(5):508-16.
2004: Paco M J Welsing; P L C M van Riel
The Nijmegen inception cohort of early rheumatoid arthritis.
The Journal of rheumatology. Supplement 2004;69():14-21.
2004: Timothy Radstake; Barbara Franke; Suzanne Hanssen; Mihai G Netea; Paco M J Welsing; Pilar Barrera; Leo A B Joosten; P L C M van Riel; Wim B van den Berg
The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome.
Arthritis and rheumatism 2004;50(3):999-1001.
2004: Jaap Fransen; Jos W R Twisk; M C W Creemers; P L C M van Riel
Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis.
Arthritis and rheumatism 2004;51(1):124-7.
2004: Jaap Fransen; P L C M van Riel
Are better endpoints and better design of clinical trials needed?
Best practice & research. Clinical rheumatology 2004;18(1):97-109.
2004: Rolf Rau; S Simianer; P L C M van Riel; L B A Van De Putte; K Krüger; Manfred Schattenkirchner; C F Allaart; F C Breedveld; Joachim Kempeni; K Beck; Hartmut Kupper
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate.
Scandinavian journal of rheumatology 2004;33(3):145-53.
2003: L B A Van De Putte; Rolf Rau; F C Breedveld; Joachim R Kalden; Michel Malaise; P L C M van Riel; Manfred Schattenkirchner; P Emery; Gerd R Burmester; H Zeidler; H M Moutsopoulos; K Beck; Hartmut Kupper
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.
Annals of the rheumatic diseases 2003;62(12):1168-77.
2003: P L C M van Riel
Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate.
Clinical and experimental rheumatology 2003;21(6):695-6.
2003: Marcel Flendrie; M C W Creemers; Paco M J Welsing; Alfons A den Broeder; P L C M van Riel
Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62 Suppl 2():ii30-3.
2003: Pilar Barrera; Wim J G Oyen; Otto Boerman; P L C M van Riel
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(9):825-8.
2003: Milan Tjioe; M J P Gerritsen; Alfons A den Broeder; Candida A E M van Hooijdonk; E J A Kroot; P L C M van Riel; Pilar Barrera; P C M van de Kerkhof
Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients.
Experimental dermatology 2003;12(4):460-5.
2003: Niek de Vries; Paul P Tak; Henk Tijssen; P L C M van Riel; L B A Van De Putte
Female sex increases risk for rheumatoid arthritis only in individuals encoding low-risk HLA-DRB1 alleles.
Arthritis and rheumatism 2003;48(6):1762-3.
2003: George Wells; Jennifer Anderson; Maarten Boers; David T Felson; Turid Heiberg; Sarah Hewlett; Kent Johnson; John Kirwan; Marissa Lassere; Vivian Robinson; Beverley Shea; Lee Simon; Vibeke Strand; P L C M van Riel; Peter Tugwell
MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.
The Journal of rheumatology 2003;30(5):1115-8.
2003: George Wells; Maarten Boers; Beverley Shea; Jennifer Anderson; David T Felson; Kent Johnson; John Kirwan; Marissa Lassere; Vivian Robinson; Lee Simon; Vibeke Strand; P L C M van Riel; Peter Tugwell
MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.
The Journal of rheumatology 2003;30(5):1110-1.
2003: Alfons A den Broeder; Karel J M Assmann; P L C M van Riel; Jack F M Wetzels
Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis.
The Netherlands journal of medicine 2003;61(4):137-41.
2003: Rolf Rau; Oliver Sander; P L C M van Riel; L B A Van De Putte; Fritz Hasler; Michel Zaug; Johannes Kneer; Philippe van der Auwera; Randall M Stevens
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
The Journal of rheumatology 2003;30(4):680-90.
2003: Leo A B Joosten; Timothy Radstake; Erik Lubberts; Liduine Van Den Bersselaar; P L C M van Riel; P L E M van Lent; Pilar Barrera; Wim B van den Berg
Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
Arthritis and rheumatism 2003;48(2):339-47.
2003: Alfons A den Broeder; Geert J A Wanten; Wim J G Oyen; Ton H J Naber; P L C M van Riel; Pilar Barrera
Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
The Journal of rheumatology 2003;30(2):232-7.
2002: Andrea W M Evers; Floris W Kraaimaat; P L C M van Riel; Alphons J L de Jong
Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial.
Pain 2002;100(1-2):141-53.
2002: Alfons A den Broeder; L B A Van De Putte; Rolf Rau; Manfred Schattenkirchner; P L C M van Riel; Oliver Sander; Christina Binder; Helmut Fenner; Yvonne Bankmann; Raja Velagapudi; Joachim Kempeni; Hartmut Kupper
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.
The Journal of rheumatology 2002;29(11):2288-98.
2002: Frank Buttgereit; J A P da Silva; Maarten Boers; Gerd R Burmester; Maurizio Cutolo; J Jacobs; John Kirwan; L Köhler; P L C M van Riel; T Vischer; J W J Bijlsma
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.
Annals of the rheumatic diseases 2002;61(8):718-22.
2002: Alfons A den Broeder; Karel J M Assmann; P L C M van Riel; Jack F M Wetzels
Nephrotic syndrome associated with anti-tumor necrosis factor alpha therapy in a patient with rheumatoid arthritis: comment on the article by Charles et al.
Arthritis and rheumatism 2002;46(6):1691-3; author reply 1693.
2002: Alfons A den Broeder; M C W Creemers; Anke M van Gestel; P L C M van Riel
Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha.
Rheumatology (Oxford, England) 2002;41(6):638-42.
2002: Jaap Fransen; G Stucki; P L C M van Riel
The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice?
Rheumatology (Oxford, England) 2002;41(6):601-4.
2002: Niek de Vries; P L C M van Riel; L B A Van De Putte
Research in complex diseases.
Lancet 2002;359(9313):1243-5.
2002: Pilar Barrera; A van der Maas; Annelies van Ede; B A L M Kiemeney; R F J M Laan; L B A Van De Putte; P L C M van Riel
Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(4):430-9.
2002: Niek de Vries; Henk Tijssen; P L C M van Riel; L B A Van De Putte
Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule.
Arthritis and rheumatism 2002;46(4):921-8.
2002: Alfons A den Broeder; Leo A B Joosten; T Saxne; D Heinegård; Helmut Fenner; André M M Miltenburg; W L H Frasa; Lambertus J H Van Tits; W A Buurman; P L C M van Riel; L B A Van De Putte; Pilar Barrera
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
Annals of the rheumatic diseases 2002;61(4):311-8.
2001: Hilde L Swinkels; R F J M Laan; M A van 't Hof; Désirée van der Heijde; Niek de Vries; P L C M van Riel
Modified sharp method: factors influencing reproducibility and variability.
Seminars in arthritis and rheumatism 2001;31(3):176-90.
2001: Paco M J Welsing; Anke M van Gestel; Hilde L Swinkels; L A Kiemeney; P L C M van Riel
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.
Arthritis and rheumatism 2001;44(9):2009-17.
2001: Michiel M Zandbelt; Paco M J Welsing; Anke M van Gestel; P L C M van Riel
Health Assessment Questionnaire modifications: is standardisation needed?
Annals of the rheumatic diseases 2001;60(9):841-5.
2001: S Kuiper; Anke M van Gestel; Hilde L Swinkels; Theo M de Boo; J A da Silva; P L C M van Riel
Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis.
The Journal of rheumatology 2001;28(8):1809-16.
2001: Andrea W M Evers; Floris W Kraaimaat; P L C M van Riel; J W Bijlsma
Cognitive, behavioral and physiological reactivity to pain as a predictor of long-term pain in rheumatoid arthritis patients.
Pain 2001;93(2):139-46.
2001: E J A Kroot; Anke M van Gestel; Hilde L Swinkels; M M Albers; L B A Van De Putte; P L C M van Riel
Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.
The Journal of rheumatology 2001;28(7):1511-7.
2001: Pilar Barrera; Leo A B Joosten; Alfons A den Broeder; L B A Van De Putte; P L C M van Riel; Wim B van den Berg
Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2001;60(7):660-9.
2001: E J A Kroot; M G Nieuwenhuizen; Maarten C de Waal Malefijt; P L C M van Riel; P C M Pasker-de Jong; R F J M Laan
Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease.
Arthritis and rheumatism 2001;44(6):1254-60.
2001: Timothy Radstake; Pilar Barrera; M J Albers; Hilde L Swinkels; L B A Van De Putte; P L C M van Riel
Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families.
The Journal of rheumatology 2001;28(5):962-7.
2001: R F J M Laan; P L C M van Riel; L B van de Putte
Leflunomide and methotrexate.
Current opinion in rheumatology 2001;13(3):159-63.
2001: JM Albers; Leena Paimela; P Kurki; K B Eberhardt; P Emery; M A van 't Hof; F H Schreuder; Marjatta Leirisalo-Repo; P L C M van Riel
Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis.
Annals of the rheumatic diseases 2001;60(5):453-8.
2001: P L C M van Riel; H R Schumacher
How does one assess early rheumatoid arthritis in daily clinical practice?
Best practice & research. Clinical rheumatology 2001;15(1):67-76.
2001: George Wells; Jennifer Anderson; D Beaton; N Bellamy; Maarten Boers; Claire Bombardier; F Breedveld; Alison Carr; Ann Cranney; Maxime Dougados; David T Felson; John Kirwan; M Schiff; Beverley Shea; Lee Simon; Josef Smolen; Vibeke Strand; Peter Tugwell; P L C M van Riel; VA Welch
Minimal clinically important difference module: summary, recommendations, and research agenda.
The Journal of rheumatology 2001;28(2):452-4.
2000: E J A Kroot; Miek A van Leeuwen; Martin H van Rijswijk; ML Prevoo; M A Van 't Hof; L B A Van De Putte; P L C M van Riel
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.
Annals of the rheumatic diseases 2000;59(12):954-8.
2000: P L C M van Riel; Anke M van Gestel
Clinical outcome measures in rheumatoid arthritis.
Annals of the rheumatic diseases 2000;59 Suppl 1():i28-31.
2000: E J A Kroot; Brigit A de Jong; Miek A van Leeuwen; Hilde L Swinkels; F H J van den Hoogen; M van't Hof; L B A Van De Putte; Martin H van Rijswijk; Walther J van Venrooij; P L C M van Riel
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
Arthritis and rheumatism 2000;43(8):1831-5.
2000: IH Kuper; ML Prevoo; Miek A van Leeuwen; P L C M van Riel; W F Lolkema; D S Postma; Martin H van Rijswijk
Disease associated time consumption in early rheumatoid arthritis.
The Journal of rheumatology 2000;27(5):1183-9.
2000: Timothy Radstake; Pilar Barrera; JM Albers; Hilde L Swinkels; L B A Van De Putte; P L C M van Riel
Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort.
Rheumatology (Oxford, England) 2000;39(3):267-73.
1999: E J A Kroot; L B A Van De Putte; P L C M van Riel
Management of therapy-resistant rheumatoid arthritis.
Baillière's best practice & research. Clinical rheumatology 1999;13(4):737-52.
1999: L B A Van De Putte; E J A Kroot; P L C M van Riel
Management of refractory rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38 Suppl 2():32-4.
1999: Niek de Vries; C van Elderen; Henk Tijssen; P L C M van Riel; L B A Van De Putte
No support for HLA-DQ encoded susceptibility in rheumatoid arthritis.
Arthritis and rheumatism 1999;42(8):1621-7.
1999: JM Albers; H H Kuper; P L C M van Riel; ML Prevoo; M A van 't Hof; Anke M van Gestel; Johan L Severens
Socio-economic consequences of rheumatoid arthritis in the first years of the disease.
Rheumatology (Oxford, England) 1999;38(5):423-30.
1999: Pilar Barrera; Timothy Radstake; JM Albers; P L C M van Riel; L B A Van De Putte
Familial aggregation of rheumatoid arthritis in The Netherlands: a cross-sectional hospital-based survey. European Consortium on Rheumatoid Arthritis families (ECRAF).
Rheumatology (Oxford, England) 1999;38(5):415-22.
1999: Esmeralda T H Molenaar; Maarten Boers; Désirée van der Heijde; G Alarcón; B Bresnihan; M Cardiel; John Edmonds; David T Felson; D E Furst; John Kirwan; Marissa Lassere; H Paulus; R Rau; P L C M van Riel; David Scott; Lee Simon; Vibeke Strand
Imaging in rheumatoid arthritis: results of group discussions.
The Journal of rheumatology 1999;26(3):749-51.
1999: Anke M van Gestel; J J Anderson; P L C M van Riel; Maarten Boers; Cees Haagsma; B Rich; G Wells; M L Lange; D T Felson
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
The Journal of rheumatology 1999;26(3):705-11.
1999: Cees Haagsma; Henk J Blom; P L C M van Riel; M A van't Hof; Belinda A J Giesendorf; D van Oppenraaij-Emmerzaal; L B A Van De Putte
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1999;58(2):79-84.
1999: IH Kuper; Miek A van Leeuwen; P L C M van Riel; W J Sluiter; N M Houtman; H A Cats; Martin H van Rijswijk
Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease.
The Journal of rheumatology 1999;26(2):268-76.
1999: R F J M Laan; Tim Jansen; P L C M van Riel
Glucocorticosteroids in the management of rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(1):6-12.
1998: Anke M van Gestel; Cees Haagsma; P L C M van Riel
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.
Arthritis and rheumatism 1998;41(10):1845-50.
1998: L B A Van De Putte; Anke M van Gestel; P L C M van Riel
Early treatment of rheumatoid arthritis: rationale, evidence, and implications.
Annals of the rheumatic diseases 1998;57(9):511-2.
1998: Tim Jansen; M Janssen; P L C M van Riel
Grand rounds in rheumatology: acute rheumatic fever or post-streptococcal reactive arthritis: a clinical problem revisited.
British journal of rheumatology 1998;37(3):335-40.
1997: Cees Haagsma; P L C M van Riel; A J de Jong; L B A Van De Putte
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
British journal of rheumatology 1997;36(10):1082-8.
1997: H H Kuper; Miek A van Leeuwen; P L C M van Riel; ML Prevoo; Pieternella Houtman; W F Lolkema; Martin H van Rijswijk
Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability.
British journal of rheumatology 1997;36(8):855-60.
1997: L B A Van De Putte; P L C M van Riel
Currently used second-line agents: do they control the disease course?
Clinical and experimental rheumatology 1997;15 Suppl 17():S71-4.
1997: Cees Haagsma; P L C M van Riel
Combination of second-line antirheumatic drugs.
Annals of medicine 1997;29(2):169-73.
1997: Anke M van Gestel; Cees Haagsma; D E Furst; P L C M van Riel
Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).
Baillière's clinical rheumatology 1997;11(1):65-82.
1997: Anke M van Gestel; P L C M van Riel
Evaluation of early rheumatoid arthritis disease activity and outcome.
Baillière's clinical rheumatology 1997;11(1):49-63.
1997: Miek A van Leeuwen; Martin H van Rijswijk; W J Sluiter; P L C M van Riel; IH Kuper; L B A Van De Putte; M B Pepys; Pieter C Limburg
Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
The Journal of rheumatology 1997;24(1):20-7.
1996: ML Prevoo; Anke M van Gestel; M A van T Hof; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score.
British journal of rheumatology 1996;35(11):1101-5.
1996: P L C M van Riel; Anke M van Gestel; L B A Van De Putte
Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers.
British journal of rheumatology 1996;35 Suppl 2():4-7.
1996: M C Creemers; M A van 't Hof; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
Disease activity in ankylosing spondylitis: selection of a core set of variables and a first set in the development of a disease activity score.
British journal of rheumatology 1996;35(9):867-73.
1996: ML Prevoo; I H Kuper; M A van't Hof; Miek A van Leeuwen; L B A Van De Putte; P L C M van Riel
Validity and reproducibility of self-administered joint counts. A prospective longitudinal followup study in patients with rheumatoid arthritis.
The Journal of rheumatology 1996;23(5):841-5.
1996: Anke M van Gestel; P L C M van Riel
American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis: comment on the article by Felson et al.
Arthritis and rheumatism 1996;39(3):535-7.
1996: Anke M van Gestel; ML Prevoo; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.
Arthritis and rheumatism 1996;39(1):34-40.
1995: P L C M van Riel; Anke M van Gestel; L B A Van De Putte
Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
British journal of rheumatology 1995;34 Suppl 2():40-2.
1995: Cees Haagsma; P L C M van Riel; L B A Van De Putte
Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
British journal of rheumatology 1995;34 Suppl 2():104-8.
1995: M J Wijnands; P L C M van Riel
Management of adverse effects of disease-modifying antirheumatic drugs.
Drug safety : an international journal of medical toxicology and drug experience 1995;13(4):219-27.
1995: L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis--changing theories and treatment modalities.
Acta orthopaedica Scandinavica. Supplementum 1995;266():10-3.
1995: L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis: new trends in therapy.
Clinical and experimental rheumatology 1995;13 Suppl 12():S27-30.
1995: P L C M van Riel; Désirée van der Heijde; I H Nuver-Zwart; L B A Van De Putte
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
The Journal of rheumatology 1995;22(9):1797-9.
1995: Désirée van der Heijde; Miek A van Leeuwen; P L C M van Riel; L B A Van De Putte
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).
The Journal of rheumatology 1995;22(9):1792-6.
1995: Miek A van Leeuwen; J Westra; Pieter C Limburg; P L C M van Riel; Martin H van Rijswijk
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
Annals of the rheumatic diseases 1995;54(8):674-7.
1995: Pilar Barrera; Cees Haagsma; AM Boerbooms; P L C M van Riel; G F Borm; L B A Van De Putte; J W Van der Meer
Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
British journal of rheumatology 1995;34(8):747-55.
1995: M C Creemers; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
Methotrexate in severe ankylosing spondylitis: an open study.
The Journal of rheumatology 1995;22(6):1104-7.
1995: Anke M van Gestel; R F J M Laan; Cees Haagsma; L B A Van De Putte; P L C M van Riel
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial.
British journal of rheumatology 1995;34(4):347-51.
1995: S ten Wolde; B A C Dijkmans; Jon van Rood; F H Claas; René R P De Vries; J M W Hazes; P L C M van Riel; Anke M van Gestel; Ferdinand C Breedveld
Human leucocyte antigen phenotypes and gold-induced remissions in patients with rheumatoid arthritis.
British journal of rheumatology 1995;34(4):343-6.
1995: Miek A van Leeuwen; J Westra; Pieter C Limburg; P L C M van Riel; Martin H van Rijswijk
Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.
Annals of the rheumatic diseases 1995;54(1):33-8.
1995: ML Prevoo; M A van 't Hof; H H Kuper; Miek A van Leeuwen; L B A Van De Putte; P L C M van Riel
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.
Arthritis and rheumatism 1995;38(1):44-8.
1995: M C Creemers; A Chang; M J Franssen; Theo J W Fiselier; P L C M van Riel
Pseudoporphyria due to naproxen. A cluster of 3 cases.
Scandinavian journal of rheumatology 1995;24(3):185-7.
1995: Miek A van Leeuwen; J Westra; P L C M van Riel; Pieter C Limburg; Martin H van Rijswijk
IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?
Scandinavian journal of rheumatology 1995;24(3):146-53.
1994: Frans G M Russel; M C Creemers; Y Tan; P L C M van Riel; F W Gribnau
Ion-pair solid-phase extraction of cimetidine from plasma and subsequent analysis by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications 1994;661(1):173-7.
1994: Cees Haagsma; P L C M van Riel; D J de Rooij; T B Vree; F J Russel; M A van't Hof; L B A Van De Putte
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.
British journal of rheumatology 1994;33(11):1049-55.
1994: M C Creemers; P L C M van Riel; M J Franssen; L B A Van De Putte; F W Gribnau
Second-line treatment in seronegative spondylarthropathies.
Seminars in arthritis and rheumatism 1994;24(2):71-81.
1994: Anke M van Gestel; R Koopman; M Wijnands; L B A Van De Putte; P L C M van Riel
Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.
The Journal of rheumatology 1994;21(10):1814-9.
1994: M C Creemers; M A Van 't Hof; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study.
British journal of rheumatology 1994;33(9):842-6.
1994: Pilar Barrera; A Van Ede; R F J M Laan; P L C M van Riel; AM Boerbooms; L B A Van De Putte
Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.
Annals of the rheumatic diseases 1994;53(7):479-80.
1994: Pilar Barrera; R F J M Laan; P L C M van Riel; P N Dekhuijzen; AM Boerbooms; L B A Van De Putte
Methotrexate-related pulmonary complications in rheumatoid arthritis.
Annals of the rheumatic diseases 1994;53(7):434-9.
1994: Miek A van Leeuwen; Désirée van der Heijde; Martin H van Rijswijk; Pieternella Houtman; P L C M van Riel; L B A Van De Putte; Pieter C Limburg
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
The Journal of rheumatology 1994;21(3):425-9.
1993: R F J M Laan; P L C M van Riel; L B A Van De Putte; L J van Erning; M A van't Hof; J Albert M Lemmens
Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.
Annals of internal medicine 1993;119(10):963-8.
1993: M J Wijnands; M A Van 't Hof; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
A prospective analysis of risk factors for the discontinuation of second-line antirheumatic drugs.
Pharmacy world & science : PWS 1993;15(5):203-7.
1993: ML Prevoo; P L C M van Riel; M A van 't Hof; Martin H van Rijswijk; Miek A van Leeuwen; H H Kuper; L B A Van De Putte
Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis.
British journal of rheumatology 1993;32(7):589-94.
1993: P L C M van Riel; W G Van Lankveld
Quality of life 3. Rheumatoid arthritis.
Pharmacy world & science : PWS 1993;15(3):93-7.
1993: Miek A van Leeuwen; Martin H van Rijswijk; Désirée van der Heijde; Gerard te Meerman; P L C M van Riel; Pieternella Houtman; L B A Van De Putte; Pieter C Limburg
The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
British journal of rheumatology 1993;32 Suppl 3():9-13.
1993: M J Wijnands; M A Van 'T Hof; L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
British journal of rheumatology 1993;32(4):313-8.
1993: Désirée van der Heijde; M van 't Hof; P L C M van Riel; L B A Van De Putte
Development of a disease activity score based on judgment in clinical practice by rheumatologists.
The Journal of rheumatology 1993;20(3):579-81.
1993: Désirée van der Heijde; M van 't Hof; P L C M van Riel; L B van de Putte
Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
The Journal of rheumatology 1993;20(3):538-41.
1993: R F J M Laan; Wilhelmina C A M Buijs; L J van Erning; J Albert M Lemmens; F H Corstens; SH Ruijs; L B A Van De Putte; P L C M van Riel
Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content.
Calcified tissue international 1993;52(1):5-9.
1993: R F J M Laan; Wilhelmina C A M Buijs; André L M Verbeek; M P Draad; Frans H M Corstens; L B A Van De Putte; P L C M van Riel
Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.
Annals of the rheumatic diseases 1993;52(1):21-6.
1992: R F J M Laan; L J van Erning; J Albert M Lemmens; L B A Van De Putte; SH Ruijs; P L C M van Riel
Single- versus dual-energy quantitative computed tomography for spinal densitometry in patients with rheumatoid arthritis.
The British journal of radiology 1992;65(778):901-4.
1992: Pilar Barrera; P L C M van Riel; A J de Jong; AM Boerbooms; L B Van de Putte
Recurrent and migratory reflex sympathetic dystrophy syndrome.
Clinical rheumatology 1992;11(3):416-21.
1992: Désirée van der Heijde; P L C M van Riel; Miek A van Leeuwen; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients.
British journal of rheumatology 1992;31(8):519-25.
1992: R F J M Laan; P L C M van Riel; L B A Van De Putte
Bone mass in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(6):826-32.
1992: M J Wijnands; M A van't Hof; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Long-term second-line treatment: a prospective drug survival study.
British journal of rheumatology 1992;31(4):253-8.
1992: R F J M Laan; P L C M van Riel; L J van Erning; J Albert M Lemmens; SH Ruijs; L B A Van De Putte
Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.
British journal of rheumatology 1992;31(2):91-6.
1992: Désirée van der Heijde; M A van't Hof; P L C M van Riel; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(2):177-81.
1992: Désirée van der Heijde; Miek A van Leeuwen; P L C M van Riel; A M Koster; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis.
Arthritis and rheumatism 1992;35(1):26-34.
1991: Désirée van der Heijde; P L C M van Riel; Miek A van Leeuwen; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis.
The Journal of rheumatology 1991;18(9):1285-9.
1991: M Wijnands; P L C M van Riel; M van 't Hof; F Gribnau; L B A Van De Putte
Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study.
The Journal of rheumatology 1991;18(2):184-7.
1991: J W G Jacobs; Johannes J Rasker; P L C M van Riel; F W Gribnau; L B A Van De Putte
Rheumajecta and vasolastine in the treatment of rheumatoid arthritis--the results of a placebo-controlled, double-blind trial of a complementary treatment.
Scandinavian journal of rheumatology 1991;20(6):434-40.
1991: M J Wijnands; I H Nuver-Zwart; P L C M van Riel; M A van 't Hof; F W Gribnau; L B A Van De Putte
Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
Scandinavian journal of rheumatology 1991;20(1):52-7.
1990: Désirée van der Heijde; M A van 't Hof; P L C M van Riel; L A Theunisse; Erik Lubberts; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Annals of the rheumatic diseases 1990;49(11):916-20.
1990: M J Wijnands; P L C M van Riel; F W Gribnau; L B A Van De Putte
[Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature].
Nederlands tijdschrift voor geneeskunde 1990;134(29):1387-91.
1990: M J Wijnands; P L C M van Riel; F W Gribnau; L B A Van De Putte
Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.
Seminars in arthritis and rheumatism 1990;19(6):337-52.
1990: M J Wijnands; C M Perret; F H van den Hoogen; L B A Van De Putte; P L C M van Riel
Chrysotherapy provoking exacerbation of contact hypersensitivity to nickel.
Lancet 1990;335(8693):867-8.
1990: Désirée van der Heijde; P L C M van Riel; I H Nuver-Zwart; L B A Van De Putte
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up.
Lancet 1990;335(8688):539.
1990: M J Wijnands; C M Perret; P L C M van Riel; L B A Van De Putte
Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritis. A case report and review of the literature.
Scandinavian journal of rheumatology 1990;19(2):167-9.
1990: Désirée van der Heijde; P L C M van Riel; L B A Van De Putte
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine.
Scandinavian journal of rheumatology 1990;19(6):407-12.
1989: Désirée van der Heijde; P L C M van Riel; I H Nuver-Zwart; F W Gribnau; L B vad de Putte
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
Lancet 1989;1(8646):1036-8.
1989: I H Nuver-Zwart; P L C M van Riel; L B A Van De Putte; F W Gribnau
A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Annals of the rheumatic diseases 1989;48(5):389-95.
1988: Désirée van der Heijde; P L C M van Riel; Martin H van Rijswijk; L B A Van De Putte
Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.
Seminars in arthritis and rheumatism 1988;17(4):284-92.